Search
Sensei Biotherapeutics Inc
SNSEAdd to Watchlist
13.850USD
0.0000.00%
Close 06/24, 16:00（ET）Quotes delayed by 15 min
632.61MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
5
analysts
Buy
Current Rating
53.750
Target Price
+201.63%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
561
Total
5
Median
6
Average
Company name
Ratings
Analysts
Sensei Biotherapeutics Inc
SNSE
5
Beigene Ltd
ONC
27
Ionis Pharmaceuticals Inc
IONS
27
CRISPR Therapeutics AG
CRSP
26
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
112
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Sensei Biotherapeutics Inc's price target?
Analysts forecast that Sensei Biotherapeutics Inc's price target is USD 32.50, with the highest forecast at USD 35.00 and the lowest forecast at USD 30.00.
How have Sensei Biotherapeutics IncSNSE's recent earnings per share performed?
The market expectation was USD -131.45, while Sensei Biotherapeutics IncSNSE's earnings per share (EPS) for the previous quarter was USD -3.74. EPS for the next quarter is expected at USD -6.40.
What is the analyst rating for Sensei Biotherapeutics Inc?
Based on the ratings of Sensei Biotherapeutics Inc's stock from 5 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
